Patients' willingness to pay for electronic communication with their general practitioner.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works matching IS 16187598 AND DT 2007 AND VI 8 AND IP 2
Results: 13
1
2
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.
- Published in:
- European Journal of Health Economics, 2007, v. 8, n. 2, p. 123, doi. 10.1007/s10198-007-0039-4
- By:
- Publication type:
- Article
3
Comment on: Should we really worry about "launch delays" of new drugs in OECD countries? by L. Garatinni and S. Ghislandi.
- Published in:
- 2007
- By:
- Publication type:
- journal article
4
The burden of type 2 diabetes in Serbia and the cost-effectiveness of its management.
- Published in:
- 2007
- By:
- Publication type:
- journal article
5
Discussion point: should governments buy drug patents?
- Published in:
- 2007
- By:
- Publication type:
- journal article
6
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
7
Systematic review of economic evaluations and cost analyses of guideline implementation strategies.
- Published in:
- European Journal of Health Economics, 2007, v. 8, n. 2, p. 111, doi. 10.1007/s10198-007-0043-8
- By:
- Publication type:
- Article
8
Pharmacoeconomic studies in Italy: a critical review of the literature.
- Published in:
- 2007
- By:
- Publication type:
- journal article
9
Should we really worry about “launch delays” of new drugs in OECD countries? Reply to J Cohen.
- Published in:
- European Journal of Health Economics, 2007, v. 8, n. 2, p. 171, doi. 10.1007/s10198-007-0056-3
- By:
- Publication type:
- Article
10
The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
11
An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany.
- Published in:
- 2007
- By:
- Publication type:
- journal article
12
Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system.
- Published in:
- 2007
- By:
- Publication type:
- journal article
13
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.
- Published in:
- 2007
- By:
- Publication type:
- journal article